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Abstract:
Approximately 70% of Americans are overweight or obese and studies have shown that
poverty-dense American counties are the most prone to obesity (Levine, 2011). Along with diet,
the endogenous circadian rhythms have been found to be an important piece of human
metabolic health. Circadian disruption in humans, such as jet-lag and shift work, have been linked
to metabolic problems such as Type 2 Diabetes Mellitus and Metabolic Syndrome. Since circadian
disruption affects many demographics including shift workers and routine business travelers it is
imperative to understand the biological mechanism behind the relationship between circadian
disruption and weight gain. One potential connection between circadian function and eating
behaviors is the Neuropeptide Y (NPY)/Peptide YY (PYY) system which causes satiety after food
intake. This study conducted three experiments (i) in a 12:12 light dark cycle (LD) were assigned
to four temporal sac groups (ZT 0, ZT 6, ZT 12, or ZT 18) (ii) in a LD mice were assigned to four
temporal injection groups (ZT 0, ZT 6, ZT 12, or ZT 18) and paired with either a PYY3-36 or vehicle
(control) (iii) mice were exposed to LD or constant light (LL) paired with either a PYY3-36 or vehicle
(control) injection during the onset of their active period, ZT 12. In the first experiment, it was
found that PYY3-36 is regulated cyclically. In the second experiment, PYY3-36 reduced food intake,
being most effective during the beginning of the night. PYY3-36 injections were also found to be
effective in inhibiting food intake regardless of the light cycle. This suggests that photic cues are
not essential for PYY3-36 active period efficacy.
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Introduction:
Circadian Rhythms
Circadian rhythms are endogenous cycles within organisms approximately 24 hours in
length which is controlled by a transcriptional-translational feedback loop in mammals.
Transcriptional activators CLOCK/BMAL1 upregulate PER1-3/CRY1-2 which throughout the day
acquire post-translational modifications which accumulate, localize to the nucleus and inhibit its
activators (Huang et al., 2011). This feedback loop occurs within the hypothalamus in a region
known as the superchiasmatic nuclei (SCN) which is the master regulator of circadian rhythms
within mammals (Fonken and Nelson 2014). Peripheral tissues are then synced to the SCN via
neural and hormonal signals; these peripheral tissues also containing core molecular clock
mechanisms (Huang et al., 2011). Without the presence of external time cues, referred to as
zeitgebers or “time givers”, circadian rhythms are free running meaning that their period is
slightly greater than 24 hours (Toh, 2008). Circadian rhythms are important in various cycles
including sleep/wakefulness, endocrine signaling, body temperature, and feeding/fasting cycles
among many others.
Light acts as the most potent zeitgeber by entraining circadian rhythms to the 24 hour
day. Light entrains the SCN through excitatory signaling through the retinohypothalamic tract
(Plano et al., 2017). External light cues are received through this tract and in turn result in
upregulation of clock genes important in resetting the internal clock. The effects of altered
lighting conditions in mice can have the following effects (i) dim light at night (DLAN) causes
increased day time activity and feeding, blunting of oscillating SCN clock genes and insulin
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sensitivity (ii) LL causes arrhythmic activity, loss of feeding rhythm, blunting of oscillating SCN
clock genes and insulin sensitivity (iii) simulated jet-lag causes sporadic activity, disrupted feeding
behavior, two altered oscillation SCN clock gene rhythms, and blunted insulin sensitivity and all
three altered light conditions result in increased body mass (reviewed by Plano et al., 2017). Thus,
light conditions play an essential role on circadian rhythms at the behavioral, biochemical, and
metabolic level.
Although the SCN syncs and couples to peripheral tissues, there are cases in which
peripheral rhythms can be out of sync from the SCN due to other external cues or peripheral
tissues adapting slowly in comparison to the SCN (Fonken & Nelson, 2014). For example in
simulated-jet lag light exposure, the SCN clock genes have two oscillations: a cycle entrained prior
to the jet-lag and a shifted cycle with the peak occurring later with the same amplitude. This
rhythm is opposite to the liver tissue clock gene oscillations that have an out of phase cycle (Plano
et al., 2017). Opposing rhythms could be influenced by additional external cues such as food
availability and locomotor activity (Fonken & Nelson, 2014). Restricted feeding can result in
anticipatory wakefulness and increases in locomotor activity and entrains circadian rhythms in
the liver (Fonken & Nelson, 2014). This provides evidence on how internal clock mechanisms not
only affect internal rhythms but how external cues can in turn affect the internal clock.
Circadian Disruption and Metabolism
In present day, urbanization is leading to increased light pollution that can in turn affect
human circadian rhythms and health. With 70% of the U.S. being overweight or obese, it is an
interesting question to investigate whether increased amount of light could be contributing to
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this multifaceted problem (Levine, 2011). Further, light pollution is not the only form of circadian
disruption affecting humans; shift workers, routine business travelers, and the use of technology
at night are all forms of altered lighting conditions that can alter circadian rhythms. Natural
compared to artificial lighting can also affect endogenous rhythms as it has been shown that
humans exposed to natural lighting compared to electrical light had less variable melatonin and
sleep rhythms (Fonken & Nelson, 2014). Human studies have found that altered lighting
conditions can have adverse impacts on metabolism. Shift workers have been found to be at a
higher risk for Metabolic Disorder and have increased body mass index (BMI) (Fonken & Nelson,
2014) and social jetlag has been found to be correlated with metabolic issues and being
overweight in individuals with non-communicable chronic diseases (Mota et al. 2017). These
studies among many others are a part of a growing body of evidence suggesting circadian
disruption from external light cues can be detrimental to human health.
Studies in humans show that circadian disruption causes metabolic problems by (i)
altering metabolic hormone levels such leptin and thyroid-stimulating hormones (Zimberg, et al
2012); (ii) increasing glucose and insulin levels, conditions commonly found in patients with
T2DM (Zimberg, et al., 2012); and (iii) that sleep restrictions lead to increased weight gain and
increased caloric intake, especially during evening or “non-active” hours (Spaeth, et al., 2013). To
this end in mice, if food availability is constrained to only the active part of the daily cycle, the
increased obesity and diabetic phenotypes are negated (Hatori et al., 2012). In addition to
circadian disruption affecting metabolism, altered metabolism such as that seen in obese
individuals can in turn affect internal hormonal rhythms and body temperature (Fonken &
Nelson, 2014).
5

Mice make great research subjects since they share circadian clock mechanisms and can
develop metabolic disorders similar to humans. Hence, mouse-based models have been used to
further investigate how circadian disruption leads to metabolic disorders. In mice, varying
photoperiods with clear implications in humans are used such as the light cycles previously
mentioned: simulated jetlag, DLAN and LL. The latter two simulate human activities from electric
light pollution like watching TV and using smartphones throughout the night.
Rodent studies provide models that can further be manipulated to have a greater
understanding as to how circadian disruption leads to metabolic disorders and weight gain. It has
been found that mice exposed to circadian disruptions such as LL, simulated jetlag, or a 20 hour
LD day exhibit increased weight gain and symptoms of T2DM and Metabolic Syndrome (Fonken,
et al 2010; Fonken et al., 2013; Karatsoreos et al., 2010). Several factors have been found to
potentially contribute to the obesogenic effects of circadian disruption. These factors include
disruption of molecular clock rhythms, disruption of hormonal signaling involved in metabolism,
alterations in sleep patterns, and alterations in feeding behavior.
Disruption of Molecular Clock Rhythms
Through the use of genetic manipulations core clock genes such as CLOCK and BMAL1
have been altered to study the consequences of mutated molecular clock genes on metabolism.
In CLOCK/BMAL1 mutants, it was found that glucose metabolism and insulin signaling have
disrupted cycles, reduced insulin secretion and, impaired glucose tolerance (Huang et al., 2011).
A conditional CLOCK mutant with no expression in the liver and skeletal muscle had reduced
insulin and impaired glucose tolerance as well suggesting peripheral tissues rhythms may play an
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important role in energy homeostasis (Kennaway et al., 2007). DLAN was found to cause
increased weight gain despite similar food intake suggesting that peripheral tissues internal
rhythm are needed for metabolic regulation (Borniger et al., 2014). Interestingly, time restricted
sleeping in wildtype mice showed hallmarks of obesity such as increased food intake and leptin
resistance however in Per 1/2 double mutants these obesogenic effects were blunted protecting
the mice (Husse et al., 2012). Together these findings suggest that core clock genes in both the
SCN and peripheral tissues are important in maintaining metabolic rhythms and targeting of
particular molecular clock components such as Per 1/2 can protect against obesogenic effects.
Disruption of Hormonal Signaling
Alterations in molecular clock rhythms can dysregulate hormones that rely on this
mechanism as a pacemaker. This includes metabolically related hormones such as insulin, leptin,
and ghrelin. It has been found that there are alterations of endocrine hormone secretion in clock
mutant mice (Fonken & Nelson, 2014). A disrupted 20 hour LD cycle resulted in increased insulin
and leptin compared to LD control (Karatsoreos et al., 2011). In BMAL1-knockout mice, insulin
secretion loses rhythmicity (Shi et al., 2013). Leptin and Ghrelin rhythms are also affected in
BMAL1 mutants (Tsang et al., 2017). Ablation of the SCN causes loss of leptin rhythms showing
that circadian rhythms and metabolic signaling are interconnected (Froy, 2010). Previously, it was
found that in a LL cycle mice exhibit symptoms of hyperthyroidism in which thyroid stimulating
hormone (TSH) was decreased and free thyroid hormone was increased along with abolishment
of leptin rhythms (Maroni et al., 2018).
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Alterations in Sleep Patterns
Changes to sleep patterns can also contribute to the metabolic problems associated with
circadian disruption. In two studies it was found that fragmented sleep can cause increased food
intake and glucose intolerance in one study and increased caloric intake and increased leptin in
the second (Baud et al., 2012; Wang et al., 2014). Sleep changes seem to be able to occur as a
result of obesity as well as it was found that a mouse model of obesity exhibited increase in
fragmented sleeping, weakened rhythmicity during REM sleep, and an increase in overall sleep
(Laposky et al., 2008).
Alterations in Feeding Behavior
This study is particularly interested in feeding behaviors and how manipulating the
temporal point in which they occur could be beneficial against the adverse effects of circadian
disruption. Circadian disruption causes altered feeding due to disrupted sleep/wake behaviors
that in turn lead to eating at different times. DLAN exposure in mice has been found to cause
increased daytime activity in nocturnal mice (Shuboni & Yan, 2010). Circadian disruption leads to
higher caloric intake due to consumption during their inactive period (day). This combination of
higher caloric intake, plus de-synchrony between overt behavior and internal physiology of an
individual, can result in a net positive energy balance and subsequent weight gain (Zimberg, et al
2012). Interestingly, increases in obesity are prevented when mice experiencing circadian
misalignment are restricted food during their active phase (nighttime as mice are nocturnal)
(Oike, et al 2015). Thus, the temporal point at which food consumption occurs is potentially a
significant factor in why circadian disruption leads to problems in overall metabolism.
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PYY/NPY System
One potential connection between circadian function and eating behaviors is the
Neuropeptide Y (NPY)/Peptide YY (PYY) system. PYY exists in two forms, PYY1-36 (untruncated
form) and PYY3-36 (truncated form), which are both secreted from the hind gut; PYY1-36 dominates
when a mammal is fasted and PYY3-36 dominates after feeding (Ballatyne, 2006; De Silva & Bloom,
2012). After secretion, circulating PYY crosses the blood brain barrier and binds to metabotropic
receptors in the arcuate nucleus (ARC) of the hypothalamus of which there are four receptor
types Y1, Y2, Y4, and Y5 (Ballatyne, 2006). PYY1-36 is nondiscriminatory as it binds to all 4 receptor
types in the ARC and promotes food intake along with another agonist NPY. During the time of
food intake however, PYY3-36 secretion increases in addition to the enzyme dipeptidyl peptidase
IV (DPP-IV) cleaving circulating PYY1-36 to PYY3-36 changing its activity to selectively binding to the
inhibitory Y2 causing a decrease in appetite (Figure 1) (Michel et al., 2008; Zac-Varghese, et al

Figure 1. PYY secretion and subsequent binding. Both forms of PYY is secreted from
the hindgut and PYY1-36 is truncated by DDP-IV which changes it to PYY3-36 the form
that selectively binds to the Y2 appetite inhibiting receptors in the ARC.
9

2010). While DPP-IV alters binding of PYY causing decreases in food intake, it inhibits other
peptides like glucagon-like peptide-1 (GLP-1) which increases insulin levels to decrease blood
sugar levels in response to feeding (Pala et al., 2003).
Previous studies show that inactivation of Y2 receptors in mice led to increased food
intake, body mass, and fat deposit (Naveilhan, et al 1999). This implies that, specifically PYY3-36
the form specific to the Y2 receptor, seems to be a potent regulator of food consumption and
metabolism. Further, when PYY3-36 was administered in humans food intake decreased whereas
PYY1-36 when administered did not have an effect on energy intake and food consumption
suggesting that PYY3-36 has greater potency in regulating food consumption compared to its full
form counterpart (Sloth et al., 2006).
The PYY/NPY system seems to be linked to circadian rhythms as NPY has been found to
be a potent cue to reset the circadian clock (Maywood, et al 2002). However, more research is
required to understand the relation between PYY and circadian rhythms. Interestingly, the phase
advancing characteristics of NPY have been found to be mediated by the Y2 receptor, the same
receptor PYY3-36 binds (Huhman, et al 1996). Further, nocturnal intraperitoneal injections of PYY336 caused decreased wakefulness in rats (Akanmu

et al., 2006). This implies a potential connection

between PYY, food consumption, and circadian rhythm that my research aims to understand.
Experimental Rationale
This study conducted three separate experiments aimed at understanding if either forms
of PYY is regulated in a cyclic manner and if PYY3-36 injections during the active (i.e., dark) periods
could alleviate the negative metabolic symptoms of circadian disruption. Both studies utilized
10

CD1 mice as this strain has been previously found to have negative metabolic consequences
when exposed to circadian disruption. DLAN caused blunting rhythms of the clock gene Per,
increased daytime activity and altered light responsiveness; LL caused a decrease in thyroid
stimulating hormone (TSH), increased free T4, and abolished day-night variation in leptin
indicating that light entrainment is important for physiological rhythms within this strain (Fonken
& Nelson 2014; Maroni et al. 2018).
Experiment 1 exposed CD1 mice to 12:12 LD cycle and sacrificed animals at one of the
four zeitgeber times ZT 0, ZT 6, ZT 12, and ZT 18. In experiment 2, mice were exposed to LD and
injected with vehicle or PYY3-36 during one of the four zeitgeber times ZT 0, ZT 6, ZT 12, or ZT 18.
Experiment 3 exposed CD1 mice to either a 12:12 LD cycle or LL. Both experiment 2 and
experiment 3 groups were paired with either a PYY3-36 or vehicle (control) injection during their
set injection which varied for experiment 2 but was set at the onset of their active period ZT 12
for experiment 3 (Figure 2). Constant light was used specifically because unlike circadian
disruptions such as DLAN and content darkness, constant light results in locomotor arrhythmicity
and blunting of body temperature and glucocorticoid rhythms, a metabolically involved hormone
(Fonken & Nelson, 2014).
It was hypothesized that there are endogenous rhythms of both forms of PYY as they are
involved in regulating food intake which is a rhythmic behavior itself. In addition, it was
hypothesized that the decreased levels of PYY3-36 during the active period would make the ZT 12
and ZT 18 time points have increased efficacy in inhibiting food intake as endogenous levels are
lower during these times. In experiment 3, it was hypothesized that the external light output in
LL could lead to downstream signaling that dysregulates peripheral tissue rhythms into
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outputting hormones as if the mouse is always in its inactive period. Thus causing PYY3-36
injections to be less effective at inhibiting food intake in LL due to the external light cues causing
an increase in endogenous PYY3-36 levels to rise.
Methods:
Experiment 1 – Endogenous Levels of PYY
Twenty-four male CD1 mice were purchased from Charles River Laboratories at
(Shrewsbury, MA) approximately 7 weeks of age and were housed individually. After arrival, all
animals were placed in a 12:12 LD cycle at 22˚C under 100 lux lighting with water ad libitum and
Lab Diet 5001 rodent chow. Mice were maintained in these conditions for 1 month and then
separated by time of day in which they would be sacrificed (ZT 0, ZT 6, ZT 12, or ZT 18). There
were four groups: (1) ZT0 (n=6), (2) ZT 12 (n=6), (3) ZT 12 (n=6), (4) ZT 18 (n=6). Within each
group, mice were fasted 12 hours prior to their scheduled sac time and whole blood was collected
and allowed to clot. Serum was obtained by centrifugation at 4˚C for 20 minutes at 2000 g,
aliquoted into microcentrifuge tubes, and stored in−80˚C.
Statistical analyses
One-way ANOVA (sac time) was used to uncover differences in endogenous PYY1-36, PYY336,

and fasting glucose.
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Experiment 2 – Physiological effects of PYY
Animals and Injections
This study had the approval of Bridgewater State University’s Institutional Animal Care
and Use Committee. Forty-eight male CD1 mice were purchased from Charles River Laboratories
at (Shrewsbury, MA) approximately 7 weeks of age and were housed individually. After arrival,
all animals were placed in a 12:12 LD cycle at 22˚C under 100 lux lighting with water ad libitum
and Lab Diet 5001 rodent chow. Mice were maintained in these conditions for 1 month and then
placed into groups either receiving an injection of 1x PBS (control) or a 1 µg/10g PYY3-36 (from a
1% PYY3-36 solution (w/v) in 1x PBS) intraperitoneal injection after a 12-hour fast and further
separated by time of day (ZT 0, ZT 6, ZT 12, or ZT 18), in a 2 × 4 study setup. Thus, there were
eight groups: (1) ZT 0/PBS (n = 6), (2) ZT 0/ PYY3-36 (n = 6), (3) ZT 6/PBS (n = 6), (4) ZT 6/ PYY3-36 (n
= 6), (5) ZT 12/PBS (n = 6), (6) ZT 12/ PYY3-36 (n = 6), (7) ZT 18/PBS (n = 6), (8) ZT 18/ PYY3-36 (n =
6). In this experimental set up animals were only handled for the following experiments during
the time point they were assigned; i.e. ZT 0, ZT 6, ZT 12, or ZT 18.
Food Consumption Protocol
Within each injection group, mice were fasted 12 hours prior to their scheduled injection
time. Mice were injected at their set ZT group and then give 20g of food. Six hours after their
injection time, food was weighed and food consumption was calculated (20g – post 6 hour food
weight) (Figure 2).
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Fasting Glucose and Hormonal
Assays
Fasting glucose levels were
measured after a 12-hour fast and
were measured using a One-Touch
Ultra-2 Glucose Monitor. Six hours
after

intraperitoneal

injection,

glucose levels were collected again
and whole blood was collected at
the aforementioned circadian time
Figure 2. Injection and food consumption protocol. Mice
were fasted for 12 hours prior to their ZT injection time,

points and allowed to clot. Serum

injected at their assigned ZT time, given food, and measured

was obtained by centrifugation at

for food consumption 6 hours after and sacrificed.

4˚C for 20 minutes at 2000 g,

aliquoted into microcentrifuge tubes, and stored in−80˚C. Levels of PYY1-36 (EIAM-PTT, Ray
Biotech, Norcross, GA), PYY3-36 (EK-059-04, Phoenix Pharmaceuticals Inc., Burlingame, CA), and
Insulin (90080, Crystal Chem, Elk Grove Village, IL) were measured using their respective ELISA
kits.
Statistical analyses
Two-way ANOVAs (injection time and injection type) were utilized to uncover differences
in PYY3-36 post-injection, insulin, food consumption, and weight change.
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Experiment 3 – Effects of constant light on PYY food inhibition
Animals and Injections
Forty-eight male CD1 mice were purchased from Charles River Laboratories (Shrewsbury,
MA) approximately 4 weeks of age and were housed individually. Circadian activity in cages were
monitored using IR-beams (StarrLife Sciences, Oakmont, PA), as previously described
(Nascimento et al. 2016b). After arrival, all animals were placed in a 12:12 LD cycle at 22 ºC under
100 lux lighting with water ad libitum and Lab Diet 5001 rodent chow. After 1-week entrainment
and acclimation, 24 mice were placed into constant light (LL) for 10 or 20 weeks (varying times
are due to receiving 20 mice 10 weeks prior to the remaining 28 mice), while the remaining were
kept under the 12:12 LD cycle. Mice were then separated into groups either receiving an injection
of 1x PBS (control) or a 1 µg/10g PYY3-36 (from a 1% PYY3-36 solution (w/v) in 1x PBS)
intraperitoneal injection after a 12-hour fast and further separated by light cycle, in a 2 × 2 study
setup. Thus, there were four groups: (1) LL/PBS (n = 12), (2) LL/ PYY3-36 (n = 12), (3) LD/PBS (n =
12), (4) LD/ PYY3-36 (n = 12). We chose to conduct this experiment at ZT 12 due to the finding that
it lead to the largest difference in food consumption patterns (see results Experiment 2) and to
determine whether LL exposure affects PYY3-36 efficacy. The food consumption effects of PYY3-36
in LL were conducted in the same manner as in Experiment 2.
Statistical analysis
Two-way ANOVAs (light cycle and injection) were utilized to uncover differences in food
consumption.
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Results:
This study first wanted to understand the circulating levels of both PYY forms at four
different time points throughout a 24-hour day. Endogenous PYY1-36 levels did not differ
throughout the four times they were measured, ZT 0, ZT 6, ZT 12, or ZT 18 (Figure 3A).
Endogenous PYY3-36 levels at ZT 6 were increased compared to ZT 12 and ZT 18 (Figure 3B, p <
0.05).
Fasting glucose levels in mice prior to a vehicle or PYY3-36 injection were significantly
higher at ZT 0, the onset of their inactive period, compared to ZT 18, halfway through their active
period (Figure 4A, p < 0.05). Regardless of injection group, there was a greater difference in
glucose levels post-injection in the ZT 18 injected group compared to the ZT 6 and ZT 0 injected
groups. Further in ZT 0 injected groups, vehicle injected groups had a greater glucose difference

A

B

25

*
0.8

20

PYY 3-36 (ng/mL)

PYY 1-36 (ng/mL)

0.6

15

10

0.4

0.2

5

0.0

0
ZT 0

ZT 6

ZT 12

Measurement Time

Figure 3. Endogenous PYY
mice. A) PYY

1-36

3-36

ZT 18

ZT 0

ZT 6

ZT 12

ZT 18

Measurement Time

levels has day/night variations but PYY

1-36

does not in CD1

levels are not significantly different throughout the day (n = 6). B) PYY

3-36

levels are increased during their inactive period and are significantly decreased during their
active period (n = 6). * indicates p<0.05 ZT difference within injection group.
16

after food consumption whereas PYY3-36 injected mice at ZT 0 had nearly no difference (Figure
4B, p < 0.05). Insulin levels were decreased in PYY3-36 injected mice compared to vehicle injected
mice regardless of the time of injection (Figure 4C, p < 0.05). Levels of PYY3-36 after injections
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were increased in the PYY3-36 injected group compared to vehicle only at ZT 12. PYY3-36 levels were
increased in the vehicle injected animals at ZT 12 compared to ZT 18 (Figure 4D, p < 0.05).
PYY3-36 injected mice consumed less food than vehicle control mice during all time periods
except for the ZT 0 injected group. Additionally, the vehicle injected ZT 12 group consumed more
compared to the ZT 0 vehicle injected group (Figure 5A, p < 0.05). PYY3-36 injected mice had
decreased body mass compared to vehicle injected mice during the ZT 18 time point. Vehicle
injected mice had increased body mass at ZT 18 compared to the ZT 6 time point (Figure 5B, p <
0.05).
PYY3-36 injected mice consumed less food than the vehicle injected mice within their
respective photoperiods (Figure 6, p < 0.05). Further, it was found that food consumption was
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higher in the LD photoperiod compared to the LL in vehicle injected mice. There was no body
mass increase in mice in LL (data not shown).
Discussion:
PYY3-36 has an Endogenous Rhythm
Due to the lack of variation found in levels in PYY1-36, it suggests that the untruncated form
does not have endogenous rhythmicity (Figure 3A). This is opposite of the truncated PYY 3-36 as it
was found to be increased halfway through the mice inactive period compared to both active
period temporal points (Figure 3B). PYY1-36 shows high binding affinity to all four Y receptors
found within the ARC whereas PYY3-36 shows high affinity specifically in the Y2 receptor
(Ballantyne, 2006). This finding along with previous studies that have shown that NPY has already

been found to bind to and act as a resetting cue through the Y2 receptor suggests that this
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receptor is specifically important in PYY/NPY rhythmicity. Further this endogenous rhythm of
PYY3-36, the form that has been found to reduce food intake, follows with the logic that feeding
should be occurring during active periods. If this rhythm were to be disrupted and feeding
occurred during the inactive period this could lead to the weight gain correlated with circadian
disruption.
Exogenous PYY3-36 Alters Insulin Production, Glucose, and PYY3-36 Levels
Fasting glucose levels were increased during the onset of the inactive period ZT 0
compared to halfway through the active period ZT18 (Figure 4A). Insulin is normally secreted in
response to increased circulating glucose levels which occurs after food intake and food intake
generally occurs during the active phase (Night ZT 12/ZT 18). Despite a lack of food intake, this
difference in glucose levels could be attributed to insulin sustaining its day/night variation. This
variation results in processing of glucose during the active period of ZT 18 but a lack of processing
during the inactive period ZT 0 resulting in the difference in glucose levels.
Decreased insulin levels in PYY3-36 injected mice aligns with previous studies in which it
was found that PYY3-36 injections result in decreased insulin levels (Figure 4C; Böttcher et al.,
1989). It has also been found that insulin levels are increased in PYY-knockout mice (Boey et al.,
2006). Since PYY3-36 reduces food intake, circulating glucose levels will begin to reduce as well
having there be less need for circulating insulin to process available glucose. Further, DPP-IV
inactivates GLP-1 decreasing insulin secretion while activating appetite suppressing PYY3-36 (Pala
et al., 2003). Therefore, these results follow with the expected outcomes in the current metabolic
point the mice are at.
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Despite all temporal points being injected with PYY3-36 there was only a significant
difference in the PYY3-36 injected versus control during the ZT 18 measurement time (Figure 4D).
This could be due to the low PYY3-36 levels endogenously expressed at ZT 18 (Figure 3B) however,
PYY3-36 levels were also low during ZT 12 in which no differences in PYY3-36 injected versus control
were found. The absence of difference in the other three temporal points ZT 0, ZT 6, and ZT 12 is
likely because PYY3-36 only has a half-life of 8 minutes so the increase in exogenous PYY3-36 likely
tapers off to basal levels by 6 hours post injection (De Silva & Bloom, 2012).
The Timing of PYY Injections Affects its Efficacy
Surprisingly, the only body mass difference between PYY3-36 versus control was at the ZT
18 injection group which was not the injection time with the greatest food consumption
difference in PYY3-36 injected versus control however, there was still a significant difference in
food consumption in the PYY3-36 compared to the vehicle control at this time (Figure 5A, 5B). As
expected, PYY3-36 reduced food intake, but our results also indicate that it is most effective during
the beginning of the night, the same time that food restriction is efficacious in alleviating obesity
and T2DM symptoms. A study in monkeys found a similar result in which PYY3-36 injections were
only able to inhibit food intake during the day time (active period) but not the night time (inactive
period) (Koegler et al., 2005). This alteration in efficacy could be due to the lower levels during
an animal’s active period. These lower circulating levels of PYY3-36 could mean that injections can
have a greater effect compared to when levels are high during the animals’ inactive period. PYY336

may competitively bind to the Y2 receptor causing anorexigenic signaling compared to other

Y2 agonists NPY and PYY1-36. Further, vehicle injected animals consumed significantly more during
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their active period ZT 18 compared to the onset of their inactive period ZT 0 which follows with
the fasting glucose data previously found (Figure 4A).
PYY Efficacy is not Affected by LL
PYY3-36 reduced food intake regardless of the cycle suggesting that photic cues did not
result in an increased secretion of PYY3-36 due to the constant external photic cues (Figure 6).
However, this cannot be confirmed until concentration of PYY3-36 is quantified. Surprisingly in this
study, there were no significant differences in body mass (data not shown). A study previously
found that CD1 strain exhibits hyper locomotion when exposed to altered light which could
explain the lack of body mass increase in LL mice and additionally LL conditions can cause
symptoms of hyper thyroidism which results in weight loss (McGowan & Coogan, 2013; Maroni
et al. 2018). As explained previously, LL affects activity and various metabolic hormones. So this
raises the question as to how PYY3-36 was still able to effectively inhibit food intake when the
internal rhythms of both the SCN and peripheral tissues are likely out of phase. One explanation
could have to do with the PYY3-36 levels being blunted overall. In experiment 2, it was found that
PYY3-36 injections were able to significantly reduce food intake at ZT 6, ZT 12, and ZT 18 being
most effective when the endogenous levels were the lowest. This finding paired with experiment
3 could mean that instead of the external photic cues causing increased PYY3-36 secretion or out
of phase rhythms it could be causing blunting of the PYY3-36 making it effective at all time points.
To answer this hypothesis, PYY3-36 injection efficacy would need to be tested at all time points
like in experiment 2.
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The finding that there was increased food consumption in vehicle injected mice during LD
compared to LL is of interest. This finding supports previous studies where circadian disruption
can alter feeding however it did not increase food intake. The decreased food consumption
during ZT 12 in the LL vehicle injected mice could be indicating that there may be increased
anorexigenic signals like PYY3-36 and leptin however this does not align with the the finding that
PYY3-36 was effective at reducing food intake at this time. The decreased feeding in the vehicle LL
mice could mean that feeding times are shifted to a different ZT as well and due to their
unpredictable arrhythmic behavior the vehicle mice happened to be tested at a time point that
they were inactive and not eating as much. Monitoring the feeding behaviors of CD1 mice
exposed to constant light would be needed to understand if testing them at an inactive time
caused the reduced food intake in vehicle LL mice.
Conclusions
Overall, this study provides evidence that PYY3-36 has an endogenous rhythm and although
it reduces food intake when injected at ZT 6, ZT 12, and ZT 18 it is most efficacious at ZT 12. The
effectiveness of PYY3-36 in LL could mean that it could potentially be used to inhibit food intake
and reduce weight gain in circadian disrupted individuals. Endogenous PYY3-36 and insulin levels
in experiment 3 are still needed to have a better understanding of the cause behind different
food consumption in the vehicle LD versus vehicle LL but not the PYY3-36 LD versus PYY3-36 LL. This
research underscores the importance of an individual’s circadian clock and how circadian
disruption relates to food consumption. This will also give a better understanding of PYY3-36 and
the timing of food consumption and their potential to alleviate metabolic problems caused by
poor diet and circadian misalignment.
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